For: | Deng GM, Song HB, Du ZZ, Xue YW, Song HJ, Li YZ. Evaluating the influence of sarcopenia and myosteatosis on clinical outcomes in gastric cancer patients undergoing immune checkpoint inhibitor. World J Gastroenterol 2024; 30(8): 863-880 [PMID: 38516238 DOI: 10.3748/wjg.v30.i8.863] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v30/i8/863.htm |
Number | Citing Articles |
1 |
Vasile Bintintan, Claudia Burz, Irena Pintea, Adriana Muntean, Diana Deleanu, Iulia Lupan, Gabriel Samasca. Predictive Factors of Immunotherapy in Gastric Cancer: A 2024 Update. Diagnostics 2024; 14(12): 1247 doi: 10.3390/diagnostics14121247
|
2 |
Taha Koray Sahin, Deniz Can Guven. Prognostic impact of myosteatosis on survival with immune checkpoint inhibitors: A systematic review and meta-analysis. Clinical Nutrition ESPEN 2024; 63: 829 doi: 10.1016/j.clnesp.2024.08.015
|
3 |
Yu-Nuo Yang, Li-Sheng Wang, Yan-Qi Dang, Guang Ji. Evaluating the efficacy of immunotherapy in gastric cancer: Insights from immune checkpoint inhibitors. World Journal of Gastroenterology 2024; 30(32): 3726-3729 doi: 10.3748/wjg.v30.i32.3726
|